Composite Polylactic-Methacrylic Acid Copolymer Nanoparticles for the Delivery of Methotrexate
Figure 2
(a) Sizeplot depicting the sizes of different PLA/MAA nanoparticle formulations, (b) monomodal size distribution for the optimized PLA/MAA nanoparticle formulation, and (c) monomodal size distribution for the final PLA/MAA formulation.
